Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas After Liver Transplantation
IPMN progression is rare after liver transplantation even over an extended follow-up period. The findings were notable for the absence of an association between IPMN progression and immunosuppression regimen. Larger studies are needed given the low incidence.
Authors
- Bradley Busebee (ORCID: https://orcid.org/0000-0001-6823-3669)
- Shounak Majumder (ORCID: https://orcid.org/0000-0001-7687-049X)
- Naoki Takahashi (ORCID: https://orcid.org/0000-0002-7946-6078)
- Kymberly D. Watt (ORCID: https://orcid.org/0000-0003-0828-0644)
- Jerry Yung‐Lun Chin (ORCID: https://orcid.org/0000-0003-4089-7345)
- Brad Johnson (ORCID: https://orcid.org/0000-0003-4227-8062)
- Kristin C. Mara (ORCID: https://orcid.org/0000-0002-8783-0191)
Institutions
- Mayo Clinic (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1111/ctr.15431
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00